Rousseau Jon B's Form 4 filing
BrightSpring Health Services, Inc. (BTSG) · filed Jun 13, 2025
- Accession no.
- 0000908834-25-000196
- Filed
- Jun 13, 2025
- Trade date
- Jun 12, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $11.6M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rousseau Jon BCIK 0001579775 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | Common Stock | MOption exerciseAcquired | +531,840 | $6.37 | +$3,387,820.8 | 1,715,973 | Direct | |
| Jun 12, 2025 | Common Stock | SSaleDisposed | −531,840 | $21.75F1 | −$11,567,520 | 1,184,133 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | Common Stock | MOption exerciseDisposed | −531,840 | $0.00 | $0 | 795,241 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on June 12, 2025, at a price of $21.75, before deducting underwriting discounts and commissions.
Referenced by the price of 1 transaction in Table I.
Remarks
Title: Chairman, President and Chief Executive Officer